284 related articles for article (PubMed ID: 31853324)
1. MicroRNA-138 inhibits tumor growth and enhances chemosensitivity in human cervical cancer by targeting H2AX.
Yuan M; Zhao S; Chen R; Wang G; Bie Y; Wu Q; Cheng J
Exp Ther Med; 2020 Jan; 19(1):630-638. PubMed ID: 31853324
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin.
Yin Z; Ren W
Onco Targets Ther; 2019; 12():759-771. PubMed ID: 30774364
[TBL] [Abstract][Full Text] [Related]
3. MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1.
Wang JM; Ju BH; Pan CJ; Gu Y; Li MQ; Sun L; Xu YY; Yin LR
Am J Transl Res; 2017; 9(8):3541-3557. PubMed ID: 28861147
[TBL] [Abstract][Full Text] [Related]
4. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
Wang G; Wang S; Li C
Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
[TBL] [Abstract][Full Text] [Related]
5. miR-584 inhibits cell proliferation, migration and invasion
Wang T; Feng J; Zhang A
Exp Ther Med; 2020 Mar; 19(3):2059-2066. PubMed ID: 32104266
[TBL] [Abstract][Full Text] [Related]
6. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-708 Suppresses Cell Proliferation and Enhances Chemosensitivity of Cervical Cancer Cells to cDDP by Negatively Targeting Timeless.
Zou X; Zhu C; Zhang L; Zhang Y; Fu F; Chen Y; Zhou J
Onco Targets Ther; 2020; 13():225-235. PubMed ID: 32021269
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-154-5p regulates the HPV16 E7-pRb pathway in Cervical Carcinogenesis by targeting CUL2.
Zhao W; Liu Y; Zhang L; Ding L; Li Y; Zhang H; Wang T; Hao M
J Cancer; 2020; 11(18):5379-5389. PubMed ID: 32742484
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer.
Zhou N; Fei D; Zong S; Zhang M; Yue Y
Oncol Lett; 2016 Nov; 12(5):3633-3639. PubMed ID: 27900047
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS.
Xiao Y; Deng T; Su C; Shang Z
Oncol Lett; 2017 Jun; 13(6):4986-4994. PubMed ID: 28599501
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047.
Guo J; Chen M; Ai G; Mao W; Li H; Zhou J
Biomed Pharmacother; 2019 Jul; 115():108957. PubMed ID: 31082770
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101 regulates the viability and invasion of cervical cancer cells.
Lin C; Huang F; Shen G; Yiming A
Int J Clin Exp Pathol; 2015; 8(9):10148-55. PubMed ID: 26617722
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
15. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
17. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
Duan H; Li X; Chen Y; Wang Y; Li Z
Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
19. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92 regulates cervical tumorigenesis and its expression is upregulated by human papillomavirus-16 E6 in cervical cancer cells.
Yu Y; Zhang Y; Zhang S
Oncol Lett; 2013 Aug; 6(2):468-474. PubMed ID: 24137349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]